Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1976 2
1988 1
1989 1
1990 1
1991 1
1992 1
1993 1
1994 2
1999 3
2003 2
2004 3
2005 2
2006 1
2007 2
2008 2
2009 3
2010 4
2011 9
2012 5
2013 8
2014 11
2015 10
2016 15
2017 13
2018 14
2019 12
2020 13
2021 16
2022 21
2023 13
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-infiltrating lymphocytes in the immunotherapy era.
Paijens ST, Vledder A, de Bruyn M, Nijman HW. Paijens ST, et al. Among authors: de bruyn m. Cell Mol Immunol. 2021 Apr;18(4):842-859. doi: 10.1038/s41423-020-00565-9. Epub 2020 Nov 2. Cell Mol Immunol. 2021. PMID: 33139907 Free PMC article. Review.
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
León-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Singh N, Pollock PM, Bessette P, Fyles A, Haie-Meder C, Smit VTHBM, Edmondson RJ, Putter H, Kitchener HC, Crosbie EJ, de Bruyn M, Nout RA, Horeweg N, Creutzberg CL, Bosse T; TransPORTEC consortium. León-Castillo A, et al. Among authors: de bruyn m. J Clin Oncol. 2020 Oct 10;38(29):3388-3397. doi: 10.1200/JCO.20.00549. Epub 2020 Aug 4. J Clin Oncol. 2020. PMID: 32749941 Free PMC article.
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
Hong C, Schubert M, Tijhuis AE, Requesens M, Roorda M, van den Brink A, Ruiz LA, Bakker PL, van der Sluis T, Pieters W, Chen M, Wardenaar R, van der Vegt B, Spierings DCJ, de Bruyn M, van Vugt MATM, Foijer F. Hong C, et al. Among authors: de bruyn m. Nature. 2022 Jul;607(7918):366-373. doi: 10.1038/s41586-022-04847-2. Epub 2022 Jun 15. Nature. 2022. PMID: 35705809
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Vermij L, Léon-Castillo A, Singh N, Powell ME, Edmondson RJ, Genestie C, Khaw P, Pyman J, McLachlin CM, Ghatage P, de Boer SM, Nijman HW, Smit VTHBM, Crosbie EJ, Leary A, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC consortium. Vermij L, et al. Mod Pathol. 2022 Oct;35(10):1475-1483. doi: 10.1038/s41379-022-01102-x. Epub 2022 Jun 25. Mod Pathol. 2022. PMID: 35752743 Free PMC article. Clinical Trial.
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Horeweg N, Workel HH, Loiero D, Church DN, Vermij L, Léon-Castillo A, Krog RT, de Boer SM, Nout RA, Powell ME, Mileshkin LR, MacKay H, Leary A, Singh N, Jürgenliemk-Schulz IM, Smit VTHBM, Creutzberg CL, Koelzer VH, Nijman HW, Bosse T, de Bruyn M; TransPORTEC consortium. Horeweg N, et al. Among authors: de bruyn m. Nat Commun. 2022 Mar 16;13(1):1373. doi: 10.1038/s41467-022-29040-x. Nat Commun. 2022. PMID: 35296668 Free PMC article.
Prediction of recurrence risk in endometrial cancer with multimodal deep learning.
Volinsky-Fremond S, Horeweg N, Andani S, Barkey Wolf J, Lafarge MW, de Kroon CD, Ørtoft G, Høgdall E, Dijkstra J, Jobsen JJ, Lutgens LCHW, Powell ME, Mileshkin LR, Mackay H, Leary A, Katsaros D, Nijman HW, de Boer SM, Nout RA, de Bruyn M, Church D, Smit VTHBM, Creutzberg CL, Koelzer VH, Bosse T. Volinsky-Fremond S, et al. Among authors: de bruyn m. Nat Med. 2024 Jul;30(7):1962-1973. doi: 10.1038/s41591-024-02993-w. Epub 2024 May 24. Nat Med. 2024. PMID: 38789645 Free PMC article.
Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches.
Hendriks D, Choi G, de Bruyn M, Wiersma VR, Bremer E. Hendriks D, et al. Among authors: de bruyn m. Int Rev Cell Mol Biol. 2017;331:289-383. doi: 10.1016/bs.ircmb.2016.10.002. Epub 2017 Jan 27. Int Rev Cell Mol Biol. 2017. PMID: 28325214 Review.
Environmental DNA for wildlife biology and biodiversity monitoring.
Bohmann K, Evans A, Gilbert MT, Carvalho GR, Creer S, Knapp M, Yu DW, de Bruyn M. Bohmann K, et al. Among authors: de bruyn m. Trends Ecol Evol. 2014 Jun;29(6):358-67. doi: 10.1016/j.tree.2014.04.003. Epub 2014 May 10. Trends Ecol Evol. 2014. PMID: 24821515 Review.
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.
Grau Bejar JF, Yaniz Galende E, Zeng Q, Genestie C, Rouleau E, de Bruyn M, Klein C, Le Formal A, Edmond E, Moreau M, Plat A, Gouy S, Maulard A, Pautier P, Michels J, Oaknin A, Colomba-Blameble E, Leary A. Grau Bejar JF, et al. Among authors: de bruyn m. J Immunother Cancer. 2024 Jul 1;12(7):e009143. doi: 10.1136/jitc-2024-009143. J Immunother Cancer. 2024. PMID: 38955419 Free PMC article.
192 results